Farouq Qaqish
Family Medicine · Omaha, NENPI 1821148826
Payments from drug & device makers
Across 330 payments — averaging $19.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Novo Nordisk$950
- Amgen$824
- AbbVie$727
- Bayer$337
- Lilly USA, LLC$256
- plus $2K from 28 others
What the payments were for
- Food & beverage$6,543100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 25 | $1,799 |
| Novo Nordisk | 84 | $950 |
| Amgen | 38 | $824 |
| AbbVie(2 entities) | 48 | $727 |
| Bayer | 16 | $337 |
| Lilly USA, LLC | 22 | $256 |
| Amarin Pharma, Inc. | 13 | $189 |
| Biohaven Pharmaceutical Holding Company Ltd. | 10 | $145 |
| Johnson & Johnson(2 entities) | 9 | $140 |
| Mayne Pharma Commercial LLC | 1 | $125 |
| Genentech USA, Inc. | 6 | $102 |
| Biohaven Pharmaceuticals, Inc. | 4 | $82 |
| Pfizer | 6 | $81 |
| Ironshore Pharmaceuticals Inc. | 1 | $80 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $79 |
| GSK | 6 | $79 |
| Esperion Therapeutics, Inc. | 4 | $59 |
| Kowa Pharmaceuticals America, Inc. | 4 | $50 |
| Abbott | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $42 |
| Idorsia Pharmaceuticals US Inc | 3 | $38 |
| Sanofi-aventis U.S. LLC | 2 | $38 |
| Ultragenyx Pharmaceutical Inc. | 2 | $34 |
| Ironwood Pharmaceuticals, Inc | 2 | $32 |
| Eisai Inc. | 2 | $32 |
| E.r. Squibb & Sons, L.L.C. | 2 | $29 |
| Novartis | 1 | $28 |
| Teva Pharmaceuticals USA, Inc. | 2 | $27 |
| Boston Scientific | 1 | $26 |
| Jazz Pharmaceuticals Inc. | 1 | $17 |
| Scilex Pharmaceuticals Inc. | 1 | $15 |
| Astellas Pharma US Inc | 1 | $14 |
| Xeris Pharmaceuticals, Inc. | 1 | $13 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,543 in reported general payments places this provider in the 90th percentile of 981 family medicine providers in Nebraska.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 14 | $111 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Omaha
- Kenneth BladOmaha$1.6M
- Ralph HaukeOmaha$657K
- Darin GregoryOmaha$423K
- Gregston NelsonOmaha$147K
- Birgit KhandalavalaOmaha$107K
- John HallgrenOmaha$94K
- Gerard StanleyOmaha$50K
- Kent JohnsonOmaha$16K
- Yongge LiuOmaha$15K
- M DadaOmaha$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.